Your browser doesn't support javascript.
loading
Prevalence of hepatitis A viral RNA and antibodies among Chinese blood donors.
Sun, P; Su, N; Lin, F Z; Ma, L; Wang, H J; Rong, X; Dai, Y D; Li, J; Jian, Z W; Tang, L H; Xiao, W; Li, C Q.
Affiliation
  • Sun P; Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, China.
  • Su N; Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, China.
  • Lin FZ; Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, China lfangzhao@126.com.
  • Ma L; Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, China.
  • Wang HJ; Blood Center of the Beijing Red Cross, Beijing, China.
  • Rong X; Guangzhou Blood Center, Guangzhou, China.
  • Dai YD; Blood Center of the Nanjing Red Cross, Nanjing, China.
  • Li J; Shaanxi Blood Center, Xian, China.
  • Jian ZW; Deyang Center Blood Station, Deyang, China.
  • Tang LH; Suzhou Center Blood Station, Suzhou, China.
  • Xiao W; Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, China.
  • Li CQ; Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, China.
Genet Mol Res ; 14(4): 16431-7, 2015 Dec 09.
Article in En | MEDLINE | ID: mdl-26662440
ABSTRACT
Like other developing countries, China was reported to have a relatively high seroprevalence of anti-hepatitis A antibodies (anti-HAV). However, no studies have evaluated the prevalence of anti-HAV and HAV RNA among voluntary blood donors with or without elevated serum alanine transaminase (ALT) levels. Anti-HAV antibodies were detected using an enzyme-linked immunosorbent assay, and reverse transcription quantitative polymerase chain reaction was carried out for detection of HAV RNA. In the current study, we analyzed a total of 450 serum samples with elevated ALT levels (≥40 U/L) and 278 serum samples with non-elevated ALT levels. Seroprevalence rates of anti-HAV were 51.6% in donors with elevated ALT and 41.4% in donors with non-elevated ALT; however, none of the samples was positive for HAV RNA. The results of our study showed lower seroprevalence rates of anti-HAV in blood donors (irrespective of ALT levels) than those in published data on Chinese populations. Although donors with elevated ALT had statistically higher prevalence rates of anti- HAV than did those with non-elevated ALT, none of the serum samples had detectable levels of the active virus. In conclusion, our results demonstrate that the transmission of hepatitis A by blood transfusion will occur rarely.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis A Virus, Human / Hepatitis A Type of study: Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Genet Mol Res Journal subject: BIOLOGIA MOLECULAR / GENETICA Year: 2015 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis A Virus, Human / Hepatitis A Type of study: Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Genet Mol Res Journal subject: BIOLOGIA MOLECULAR / GENETICA Year: 2015 Type: Article Affiliation country: China